The extracellular human melanoma inhibitory activity (MIA) protein adopts an SH3 domain-like fold

EMBO Journal

Volumn 20, Issue 3, 2001, Pages 340-349

  Stoll, Raphael ^a   Renner, Christian ^a   Zweckstetter, Markus ^a   Brüggert, Michael ^a   Ambrosius, Dorothee ^b   Palme, Stefan ^b   Engh, Richard A ^b   Golob, Michaela ^c   Breibach, Ines ^c   Buettner, Reinhard ^c   Voelter, Wolfgang ^d   Holak, Tad A ^a   Bosserhoff, Anja Katrin ^c  

^a MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^b ROCHE DIAGNOSTICS GMBH   (Germany)

^c UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^d UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Extracellular SH3 domain; Fibronectin; Melanoma; MIA; NMR

Indexed keywords

FIBRONECTIN; INTEGRIN; MELANOMA INHIBITORY PROTEIN; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BIOASSAY; CANCER STAGING; DISULFIDE BOND; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE SPECTROSCOPY; HUMAN; MELANOMA; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHAGE DISPLAY; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FOLDING; PROTEIN PROTEIN INTERACTION; PROTEIN SECONDARY STRUCTURE; PROTEIN TERTIARY STRUCTURE; SEQUENCE ANALYSIS; STEREOCHEMISTRY;

AMINO ACID SEQUENCE; BINDING SITES; EXTRACELLULAR MATRIX PROTEINS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MELANOMA; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; PEPTIDE LIBRARY; PROTEIN FOLDING; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; SRC HOMOLOGY DOMAINS;

EID: 17744395294     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/20.3.340     Document Type: Article

References (73)

1. A rapid in vitro assay for quantitating the invasive potential of tumour cells
2. Localization of the major heparin-binding site in fibronectin
3. MLEV-17-based two-dimensional homonuclear magnetization transfer spectroscopy
4. Evidence that binding to the carboxy-terminal heparin-binding domain (HepII) dominates the interaction between plasma fibronectin and heparin
5. Cloning of a novel malignant melanoma-derived growth regulatory protein, MIA
6. Autocrine tumour cell growth inhibiting activities from human malignant melanoma
7. Melanoma-inhibiting activity, a novel serum marker for progression of malignant melanoma
8. MIA (Melanoma Inhibitory Activity). Biological functions and clinical relevance
9. Analysis of cell signalling by MIA in active detachment of melanoma cells
10. Coherence transfer by isotropic mixing: Application to proton correlation spectroscopy
11. High-level expression of recombinant genes in Escherichia coli is dependent on the availability of the dnaY gene product
12. Efficiency in multidimensional NMR by optimized recording of time point-phase pairs in evolution periods and their selective linear transformation
13. SH3 domains and drug design: Ligands, structure, and biological function
14. S100-β, Melanoma inhibiting activity, and lactate dehydrogenase discriminate progressive from nonprogressive American Joint Committee on Cancer stage IV melanoma
15. An improved homonuclear TOCSY experiment with minimal water saturation
16. Cloning of a retinoic acid-sensitive mRNA expressed in cartilage and during chondrogenesis
17. Structural features of fibronectin synthetic peptide FN-C/H II, responsible for cell adhesion, neurite extension and heparan binding
18. Melanoma-inhibitory activity protein, a useful marker to monitor patients treated with immunotherapy
19. Practical introduction to theory and implementation of multinuclear, multidimensional nuclear magnetic resonance experiments
20. 15N NMR relaxation
21. Two binding orientations for peptides to the Src SH3 domain: Development of a general model for SH3-ligand interactions
22. Structural requirements for biological activity of the ninth and tenth FIII domains of human fibronectin
23. Correlating backbone amide and side-chain resonances in larger proteins by multiple relayed triple resonance NMR
24. Improved 3D triple-resonance NMR techniques applied to a 31 kDa protein
25. Determination of the complete three-dimensional structure of the trypsin inhibitor from squash seeds in aqueous solution by nuclear magnetic resonance and a combination of distance geometry and dynamical simulated annealing
26. Protein structure comparison by alignment of distance matrices
27. 3J(NC)γ couplings in isotopically enriched proteins
28. 1 angles of aromatic residues in proteins from 3-bond J(C'C-γ) and J(NC-γ) couplings
29. Interaction of heparin with fibronectin and isolated fibronectin domains
30. Characterization of selected strongly and weakly invasive sublines of a primary human melanoma cell line and isolation of subtractive cDNA clones
31. Improved accuracy of NMR structures by a modified NOESY-HSQC experiment
32. Optimal sampling strategies for the measurement of spin-spin relaxation times
33. Enhanced genome annotation using structural profiles in the program 3D-PSSM
34. Determination of the disulphide bonding pattern in proteins by local and global analysis of nuclear magnetic resonance data. Application to flavoridin
35. SH2 and SH3 domains: Elements that control interactions of cytoplasmic signaling proteins
36. MOLMOL: A program for display and analysis of macromolecular structures
37. NOE spectroscopy, water suppression, and water flip-back. Use of a water flip-back pulse in the homonuclear NOESY experiment
38. Rapid recording of 2D NMR-spectra without phase cycling - Application to the study of hydrogen-exchange in proteins
39. 15N Hartman-Hahn-multiple quantum coherence and nuclear Overhauser-multiple quantum coherence spectroscopy: Application to interleukin 1β
40. The folding transition state between SH3 domains is conformationally restricted and evolutionarily conserved
41. NMR analysis of interacting soluble forms of the cell-cell recognition molecules CD2 and CD48
42. Localization and chemical synthesis of fibronectin peptides with melanoma adhesion and heparin binding activities
43. 1 receptor on HL-60 cells
44. 3 located in the C-terminal heparin-binding domain of human plasma fibronectin
45. A novel peptide-SH3 interaction
46. Improved sensitivity of HSQC spectra of exchanging protons at short interscan delays using a new fast HSQC (FHSQC) detection scheme that avoids water saturation
47. 1 in the COOH-terminal heparin-binding domain of fibronectin
48. 1-mediated melanoma cell adhesion and migration on vascular cell adhesion molecule-1 (VCAM-1) and the alternatively spliced IIICS region of fibronectin
49. Biological and regulatory properties of Vav-3, a new member of the vav family of oncoproteins
50. Structure of interleukin 16 resembles a PDZ domain with an occluded peptide binding site
51. MIA (melanoma inhibitory activity): A potential serum marker for rheumatoid arthritis
52. High-resolution crystal structures of tyrosine kinase SH3 domains complexed with proline-rich peptides
53. Fibronectin structure and assembly
54. 1H-NMR spectra of proteins via double quantum filtering
55. 1H dipole-dipole relaxation cross-correlation experiments
56. Experiment and theory highlight role of native state topology in SH3 folding
57. SMART: A web-based tool for the study of genetically mobile domains
58. Iterative schemes for bilinear operators - Application to spin decoupling
59. Crystal structure of a heparin- and integrin-binding segment of human fibronectin
60. Discovering high-affinity ligands for proteins: SAR by NMR
61. 15N HSQC experiments optimized to retain full sensitivity
62. 9 in water/fluoroalcohol solution determined by NMR spectroscopy
63. 15N assignment of the human melanoma inhibitory activity (MIA) protein
64. An optimized 3D NOESY-HSQC
65. 1H dipolar cross-correlation rates
66. Identification of melanoma inhibitory activity and other differentially expressed messenger RNAs in human melanoma cell lines with different metastatic capacity by messenger RNA differential display
67. 15N-enriched proteins
68. Relationship between nuclear magnetic shift and protein secondary structure
69. Solution structure of the SH3 domain of Src and identification of its ligand binding site
70. Structural basis for the binding of proline-rich peptides to SH3 domains